This is a Validated Antibody Database (VAD) review about rat Prl, based on 3 published articles (read how Labome selects the articles), using Prl antibody in all methods. It is aimed to help Labome visitors find the most suited Prl antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Prl synonym: Gha1; PRLB; PRLSD1; Prl1a1; Prol; RATPRLSD1; RNPROL; prolactin; growth hormone a1; prolactin family 1, subfamily a, member 1
Santa Cruz Biotechnology
| mouse monoclonal (B-8) |
| In order to outline the protocols for antibodies used for immunohistochemical studies, Santa Cruz Biotechnology Prl antibody (Santa Cruz, sc-271758) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig st13), in immunohistochemistry - paraffin section on rat samples at 1:50 (fig st13), in immunohistochemistry - paraffin section on pig samples at 1:50 (fig st13) and in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig st13). J Toxicol Pathol (2017) ncbi |
| mouse monoclonal (H-12) |
| In order to determine the relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitor effects of fenofibrate in GH3 cells to study expression of peroxisome proliferator-activated receptor alpha (PPAR-alpha) in somatotropinomas, Santa Cruz Biotechnology Prl antibody (Santa Cruz, sc-271773) was used in western blot on human samples at 1:200 (fig 5). Mol Cell Endocrinol (2016) ncbi |
R&D Systems
| goat polyclonal |
| R&D Systems Prl antibody (R&D Systems, AF1445) was used in immunohistochemistry - frozen section on axolotl samples at 2 ug/ml. Tissue Cell (2014) ncbi |
Articles Reviewed
- Rotondi S, Modarelli A, Oliva M, Rostomyan L, Sanità P, Ventura L, et al. Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells. Mol Cell Endocrinol. 2016;426:61-72 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
